CXCL6 and metabolic dysfunction-associated steatohepatitis: Moreover, CXCL6 could act as a prognostic indicator for the progression of non-alcoholic steatohepatitis (NASH) during hepatic inflammation in non-alcoholic fatty liver disease (NAFLD) patients [11].